Ethical and legal aspects of oncogenomics

Journal of B.U.ON.

Volumn 17, Issue 2, 2012, Pages 383-388

  Stankov, Karmen ^a   Draskovic, D ^a   Mikov, M ^b  

^a UNIVERSITY OF NOVI SAD   (Serbia)

^b UNIVERSITY OF NOVI SAD   (Serbia)

Author keywords

Bioethics; Oncogenomics; Personalized medicine; Translational research

Indexed keywords

BIOLOGICAL MARKER;

BIOETHICS; CLINICAL RESEARCH; GENETIC ASSOCIATION; GENETIC SCREENING; GENETIC VARIABILITY; GENOMICS; HUMAN; LEGAL ASPECT; MOLECULAR BIOLOGY; MOLECULAR GENETICS; ONCOGENOMICS; PERSONALIZED MEDICINE; PHARMACOGENOMICS; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM;

BIOMEDICAL RESEARCH; GENETIC TESTING; GENOMICS; HUMANS; INDIVIDUALIZED MEDICINE; NEOPLASMS; ONCOGENES;

EID: 84863611527     PISSN: 11070625     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (42)

1. Li J, Chen F, Cona MM et al. A review on various targeted anticancer therapies. Target Oncol 2012; doi: 10.1007/s11523-012-0212-2.
2. Weitzel JN, Blazer KR, McDonald DJ, Culver JO, Offit K. Genetics, genomics and cancer risk assessment. State of the art and future directions in the era of personalized medicine. CA Cancer J Clin 2011; 61: 327-359.
3. Henry CS, Overbeek R, Xia F. Connecting genotype to phenotype in the era of high-throughput sequencing. Biochim Biophys Acta 2011; 1810: 967-977.
4. Zhang J, Chiodini R, Badr A, Zhang G. The impact of next-generation sequencing on genomics. J Genetics Genomics 2011; 38: 95-109.
5. Di Iulio J, Rotger M. Pharmacogenomics: what is next? Front Pharmacol 2012; 2: 86.
6. Offit K. Personalized medicine: new genomics, old lessons. Hum Genet 2011; 130: 3-14.
7. Feero GW, Guttmacher AE, Collins FS. The Genome Gets Personal-Almost. JAMA 2008; 299: 1351-1352.
8. Lander ES. Initial impact of the sequencing of the human genome. Nature 2011; 470: 187-197.
9. Wolinsky H. The thousand-dollar genome. Genetic brinkmanship or personalized medicine? EMBO Rep 2007; 8: 900-903. (Pubitemid 47500469)
10. Eng C. Mendelian genetics of rare and not so rare cancers. Ann NY Acad Sci 2010; 1214: 70-82.
11. Chan IS, Ginsburg GS. Personalized medicine: progress and promise. Annu Rev Genomics Hum Genet 2011; 12: 217-244.
12. Becker F, Van El CG, Ibarreta D et al. Genetic testing and common disorders in a public health framework: how to assess relevance and possibilities. Eur J Hum Genet 2011; 19: S6-S44.
13. Meyerson M, Gabriel S, Getz G. Advances in understanding cancer genomes through second-generation sequencing. Nat Rev Genet 2010; 11: 685-697.
14. Alexandrova R. Experimental strategies in gene therapy of cancer. J BUON 2009; 14: S23-32.
15. Stankov K, Bogdanovic G, Kojic V et al. Expression analysis of genes involved in epigenetic regulation and apoptosis in human malignant haematopoietic cell lines treated with 5-aza-cytidine. J BUON 2011; 16: 116-122.
16. Cao Y, De Pinho RA, Ernst M, Vousden K. Cancer research: past, present and future. Nat Rev Cancer 2011; 11: 749-754.
17. Simonelli V, Mazzei F, D'Errico M, Dogliotti E. Gene susceptibility to oxidative damage: From single nucleotide polymorphisms to function. Mutat Res 2012; 731: 1-13.
18. Chung CC, Chanock SJ. Current status of genome-wide association studies in cancer. Hum Genet 2011; 130: 59-78.
19. Stankov K, Landi S, Gioia-Patricola L et al. GSTT1 and M1 polymorphisms in Hürthle thyroid cancer patients. Cancer Lett 2006; 240: 76-82. (Pubitemid 44055992)
20. Stankov K, Pastore A, Toschi L et al. Allelic loss on chromosomes 2q21 and 19p 13.2 in oxyphilic thyroid tumors. Int J Cancer 2004; 111: 463-467. (Pubitemid 38998831)
21. Green ED, Guyer MS, Manolio TA, Peterson JL. Charting a course for genomic medicine from base pairs to bedside. Nature 2011; 470: 204-213.
22. Kaye J, Boddington P, de Vries J, Hawkins N, Melham K. Ethical implications of the use of whole genome methods in medical research. Eur J Hum Genet 2010; 18: 398-403.
23. Harris M, Winship I, Spriggs M. Controversies and ethical issues in cancer-genetics clinics. Lancet Oncol 2005; 6: 301-310. (Pubitemid 40590267)
24. Offit K, Thom P. Ethicolegal aspects of cancer genetics. Cancer Treat Res 2010; 155: 1-14.
25. Collins F. Has the revolution arrived? Nature 2010; 464: 674-675.
26. Lewens T. What is genethics? J Med Ethics 2004; 30: 326-328. (Pubitemid 38868089)
27. McGuire A, Caulfield T, Cho MK. Research ethics and the challenge of whole-genome sequencing. Nat Rev Genet 2008; 9: 152-156. (Pubitemid 351147709)
28. Freeman BD, Kennedy CR, Frankel HL. Ethical considerations in the collection of genetic data from critically ill patients: what do published studies reveal about potential directions for empirical ethics research? Pharmacogenomics J 2010; 10: 77-85.
29. Basille C, Frydman R, El Aly A et al. Preimplantation genetic diagnosis: state of the art. Eur J Obstet Gynecol Reprod Biol 2009; 145: 9-13.
30. Konstantopoulou I, Pertesi M, Fostira F, Grivas A, Yannoukakos D. Hereditary cancer predisposition syndromes and preimplantation genetic diagnosis: where are we now. J BUON 2009; 14: S187-192.
31. Geraedts JP, De Wert GM. Preimplantation genetic diagnosis. Clin Genet 2009; 76: 315-325.
32. Dressler LN. Disclosure of Research Results from Cancer Genomic Studies: State of the Science. Clin Cancer Res 2009; 15: 4270-4276.
33. Stemerding D, Swierstra T, Boenink M. Exploring the interaction between technology and morality in the field of genetic susceptibility testing: A scenario study. Futures 2010; 42: 1133-1145.
34. O'Donnell PH, Ratain MJ. Germline pharmacogenomics in oncology: Decoding the patient for targeting therapy. Mol Oncol 2012; doi: 10.1016/j.molonc.2012. 01.005.
35. Surbone A. Social and ethical implications of BRCA testing. Ann Oncol 2011; 22: i60-i66.
36. Rogowski WH, Grosse SD, Khoury MJ. Challenges of translating genetic tests into clinical and public health practice. Nature Rev Genet 2009; 10: 489-495.
37. Fernandez CV, Gao J, Strahlendorf C et al. Providing research results to participants: attitudes and needs of adolescents and parents of children with cancer. J Clin Oncol 2009; 27: 878-883.
38. Jarvinen HJ. Genetic testing for polyposis: practical and ethical aspects. Gut 2003; 52: ii19-ii22. (Pubitemid 36523623)
39. Knoppers BM, Chadwick R. Human genetic research: emerging trends in ethics. Nat Rev Genet 2005; 6: 75-79. (Pubitemid 39657899)
40. Hudson KL. Genomics, health care and society. N Engl J Med 2011; 365: 1033-1041.
41. Lwoff L. Council of Europe adopts protocol on genetic testing for health purposes. Eur J Hum Genet 2009; 17: 1374-1377.
42. Korobkin R, Rajkumar R. The genetic information nondiscrimination act - a half-step toward risk sharing. N Engl J Med 2008; 359: 335-337.